|Videos|August 21, 2018
Exciting Advancements for Rare Blood Diseases
Author(s)Kathleen Weis, CEO
Since these are difficult diseases to treat, research has been quite slow over the last decade or so, but continues to pick up, developing new treatments for patients with these diseases.
Advertisement
There are exciting advancements being made for rare blood diseases, such as anaplastic anemia, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms like myelofibrosis, according to Kathleen Weis, CEO of the Anaplastic Anemia and MDS International Foundation.
Since these are difficult diseases to treat, research has been quite slow over the last decade or so, but continues to pick up, developing new treatments for patients with these diseases.
Music: Bensound
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us
2
FDA Grants Priority Review to Datroway for Metastatic Triple-Negative Breast Cancer
3
FDA Clears Phase 3 Trial of iSCIB1+ for Advanced Melanoma Treatment
4
What is the Goal of Multiple Myeloma Treatment?
5